Home/Filings/4/0001415889-25-006603
4//SEC Filing

Landsittel Michael 4

Accession 0001415889-25-006603

CIK 0001597264other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 5:17 PM ET

Size

7.2 KB

Accession

0001415889-25-006603

Insider Transaction Report

Form 4
Period: 2025-03-01
Landsittel Michael
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-03-01+22,00022,000 total
    Exercise: $96.57Exp: 2035-02-28Common Stock (22,000 underlying)
  • Award

    Common Stock

    2025-03-01+11,00078,208 total
Footnotes (2)
  • [F1]The reported transaction involved the Reporting Person's receipt of a grant of 11,000 restricted stock units under the Issuer's 2024 Stock Incentive Plan.
  • [F2]This option vests with respect to 1/48th of the shares underlying the option on April 1, 2025 and as to an additional 1/48th of the shares underlying the option each month thereafter.

Issuer

Blueprint Medicines Corp

CIK 0001597264

Entity typeother

Related Parties

1
  • filerCIK 0001651036

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:17 PM ET
Size
7.2 KB